Express Scripts (ESRX) Guides 2017 EPS In-Line

Go back to Express Scripts (ESRX) Guides 2017 EPS In-Line

Express Scripts Holding Company Announces 2017 Financial Guidance

December 14, 2016 7:00 AM UTC

ST. LOUIS, Dec. 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share1 for 2017 in the range of $6.82 to $7.02, representing growth of 7% to 10% from the midpoint of our 2016 adjusted EPS guidance range. 

"Our value proposition is clear; our opportunities to help patients and payers contain healthcare costs and improve clinical outcomes have never been greater," said Tim Wentworth, CEO and President. "As we continue to evolve our technological capabilities, expand the reach of our pharmacies, and enhance our patient experience, we... More